Skip to content

Clinical study of multimodal ultrasonography in predicting surgical repairability and postoperative retear of rotator cuff tear

Clinical study of multimodal ultrasonography in predicting surgical repairability and postoperative retear of rotator cuff tear

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065572
Enrollment
Unknown
Registered
2022-11-09
Start date
2022-11-21
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rotator cuff tear

Interventions

Gold Standard:Arthroscopic results of the shoulder, including rotator cuff tear type, morphology, and residual tendon quality, were the gold standard.
Index test:Philips ultrasound instrument, 4~15MHz high-frequency linear array probe, 3~14MHz three-dimensional volume probe
Esaote MyLab ultrasonic instrument, 4~13MHz linear array probe
Mindray ultrasonic instrument, 3~11MHz linear array probe

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The patient had shoulder pain, shoulder joint dysfunction and was suspected to have rotator cuff tear and was hospitalized for shoulder arthroscopic repair.

Exclusion criteria

Exclusion criteria: Patients with shoulder pain without rotator cuff tear; Previous surgical history, non-invasive treatment including NSAID and PRP therapy and/or regular exercise and/or physical therapy (TENS, ultrasound, etc.) for at least 2 months; Allergic reaction to disinfectants, anesthetics, sodium citrate and calcium chloride; Thrombocytopenia, acute and chronic infection, anticoagulant therapy, etc. Previous adverse reactions (hypertension, systemic allergy and hypersensitivity, and even severe kidney or liver diseases) occurred after local injection; Pregnancy and malignant tumors occurred within 6-12 weeks after minimally invasive treatment. Patients with severe osteoporosis near the joints; Patients unable to maintain follow-up or provide informed consent.

Design outcomes

Primary

MeasureTime frame
Two-dimensional ultrasound;Three-dimensional ultrasound;Contrast-enhanced ultrasound;Shear wave elastography;Arthroscopy;

Countries

China

Contacts

Public ContactWang Yuexiang

Chinese PLA General Hospital

wangyuexiang1999@sina.com+86 13651117366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026